GE HealthCare Technologies (GEHC) Q1 FY2026 earnings: revenue $5.1 billion, up 7.4% on the year
GE HealthCare Technologies Inc. (GEHC) reported revenue of $5.1 billion for Q1 FY2026, the quarter ended 31 March 2026, up 7.4% on the same quarter a year earlier. Net income was $389 million, down 31.0% on the year, and diluted earnings per share $0.85. The figures are the company's own, from the 10-Q it filed with the SEC on 29 April 2026.
Revenue
$5.1 billion
+7.4% on the year · -10.0% on the quarter
Q2 FY2024Q1 FY2026
Operating margin
10.0%
13.2% a year earlier
Q2 FY2024Q1 FY2026
Net income
$389 million
-31.0% on the year · -33.8% on the quarter
Q2 FY2024Q1 FY2026
Diluted EPS
$0.85
-30.9% on the year · -34.1% on the quarter
Q2 FY2024Q1 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 2 lowered, 2 kept.
Revenue rose 7.4%, organic 2.9%: Revenue was $5.1 billion, up 7.4%. Organic growth was 2.9% after excluding acquisitions of $60 million and currency effects of $155 million.
Diluted EPS fell, Adjusted EPS slightly lower: Net income attributable to GE HealthCare was $389 million, against $564 million. Diluted EPS was $0.85 against $1.23; Adjusted EPS was $0.99 against $1.01.
Pharmaceutical Diagnostics revenue up 21.7%: PDx revenue was $770 million, up 21.7%, with organic growth of 9.7% and acquisitions adding $50 million. Segment EBIT was $197 million, down 3.9%, margin 25.6%.
$ million except per share. Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
290
n/a
250
+16.0%
Capital expenditure
178
134
152
+32.8%
+17.1%
Free cash flow
112
n/a
98.0
+14.3%
Free cash flow margin
2.2%
n/a
2.1%
Cash from investing
-2,500
-269
-407
Cash from financing
21.0
-293
-286
Depreciation and amortisation
153
145
136
+5.5%
+12.5%
Share-based compensation
35.0
36.0
22.0
-2.8%
+59.1%
Buybacks
100
0.0
0.0
Dividends paid
16.0
16.0
16.0
0.0%
0.0%
Dividend per share
$0.04
n/a
$0.04
0.0%
Diluted shares, weighted
457m
457m
459m
0.0%
-0.4%
Shares outstanding at period end
455m
456m
458m
-0.2%
-0.7%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
10,668
10,379
9,187
+2.8%
+16.1%
Non-controlling interest
12.0
11.0
20.0
+9.1%
-40.0%
Redeemable equity
218
209
211
+4.3%
+3.3%
Short-term borrowings
7.0
508
2,002
-98.6%
-99.7%
Debt
10,134
10,003
8,759
+1.3%
+15.7%
Operating lease liabilities
270
284
266
-4.9%
+1.5%
Finance lease liabilities
41.0
42.0
40.0
-2.4%
+2.5%
Other liabilities
15,775
15,470
13,101
+2.0%
+20.4%
Total liabilities and equity
37,125
36,906
33,586
+0.6%
+10.5%
Goodwill
15,060
13,489
13,373
+11.6%
+12.6%
Intangible assets
1,908
1,130
1,238
+68.8%
+54.1%
Investments
352
351
235
+0.3%
+49.8%
Cash and equivalents
2,261
4,492
2,454
-49.7%
-7.9%
Inventory
2,353
2,234
2,158
+5.3%
+9.0%
Other assets
15,191
15,210
14,128
-0.1%
+7.5%
Total assets
37,125
36,906
33,586
+0.6%
+10.5%
Questions
What was GE HealthCare Technologies' revenue in Q1 FY2026?
GE HealthCare Technologies (GEHC) reported revenue of $5.1 billion for Q1 FY2026, the quarter ended 31 March 2026, up 7.4% on the same quarter a year earlier.
How much did GE HealthCare Technologies earn in Q1 FY2026?
Net income for Q1 FY2026 was $389 million, down 31.0% on the year, and diluted earnings per share $0.85.
When did GE HealthCare Technologies report Q1 FY2026 results?
GE HealthCare Technologies filed its 10-Q for the quarter ended 31 March 2026 with the SEC on 29 April 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 31 March 2026, filed 29 April 2026: the filing.